Literature DB >> 14767900

[Further study on heterogeneic basis of complement C8 beta deficiency].

Li Rao1, Ying-bi Li, Guo-di Chen, Bin Zhou, Peter M Schneider, Lin Zhang.   

Abstract

OBJECTIVE: In Caucasian population, the most common molecular basis for C8 beta deficiency s a single C to T transition in exon 9 of C8 beta gene resulting in a stop codon. In previous family studies, two individuals were identified with C8 beta complete deficiency and were found to be only heterozygous for this mutation. This study was conducted by the present authors in search of other possible causes for these two C8 beta deficient individuals.
METHODS: Using direct DNA sequence analysis of all exon-specific PCR products of the C8 beta gene from these two C8 beta deficient patients and their descendants.
RESULTS: Two other C to T transitions at base 298 and 388 in exon 3 were detected, which could also create a termination codon. The descendants from one of the deficient patients were also analysed for the mutations, and it could be demonstrated that the two C to T mutations in exons 9 and 3 are segregating independently.
CONCLUSION: These two mutations, which create a termination codon, are sufficient to explain the complete C8 beta deficiency in both patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14767900

Source DB:  PubMed          Journal:  Zhonghua Yi Xue Yi Chuan Xue Za Zhi        ISSN: 1003-9406


  2 in total

1.  A novel mutation in a patient with a deficiency of the eighth component of complement associated with recurrent meningococcal meningitis.

Authors:  D F Arnold; A G Roberts; A Thomas; B Ferry; B P Morgan; H Chapel
Journal:  J Clin Immunol       Date:  2009-05-12       Impact factor: 8.317

2.  C8B in Complement and Coagulation Cascades Signaling Pathway is a predictor for Survival in HBV-Related Hepatocellular Carcinoma Patients.

Authors:  Yuan Zhang; Xiaorong Chen; Yajuan Cao; Zongguo Yang
Journal:  Cancer Manag Res       Date:  2021-04-22       Impact factor: 3.989

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.